Most of our cases showed either a 1 + (56/112; 50%) or 2 + (51/112; 45.5%) STAT3 expression, with only 5 cases (4.5%) showing a completely negative reaction, suggesting an activation of the inflammatory pathway in our ICC cohort. Here, STAT3 is linked to intrahepatic cholangiocarcinoma.